Specific immunotherapy using Hymenoptera venom: systematic review / Imunoterapia específica com venenos de Hymenoptera: revisão sistemática

CONTEXT AND OBJECTIVE: The only effective treatment for patients who have severe reactions after Hymenoptera stings is venom immunotherapy. The aim of this study was to review the literature to assess the effects of venom immunotherapy among patients presenting severe reactions after Hymenoptera stings. DESIGN AND SETTING: Randomized controlled trials in the worldwide literature were reviewed. The manuscript was produced in the Discipline of Allergy and Clinical Immunology, Universidade de São Paulo (USP). METHODS: Randomized controlled trials involving venom immunotherapy versus placebo or only patient follow-up were evaluated. The risk of systemic reactions after specific immunotherapy was evaluated by calculating odds ratios (OR) and their 95 percent confidence intervals. RESULTS: 2,273 abstracts were identified by the keywords search. Only four studies were included in this review. The chi-square test for heterogeneity showed that two studies were homogeneous and could be included in a meta-analysis. By combining the two studies, the odds ratio became significant: 0.29 (0.10-0.87). However, analysis on the severity of the reactions after immunotherapy showed that the benefits may not be so significant because the reactions were mostly similar to or milder than the original reaction. CONCLUSIONS: Specific immunotherapy should be recommended for adults and children with moderate to severe reactions, but there is no need to prescribe it for children with skin reactions alone, especially if the exposure is very sporadic. On the other hand, the risk-benefit relation should always be assessed in each case.

CONTEXTO E OBJETIVO: O único tratamento eficaz para pacientes que têm reações graves após ferroada de Hymenoptera é a imunoterapia com veneno. O objetivo deste estudo foi rever a literatura para avaliar os efeitos da imunoterapia com veneno em pacientes com reações graves após ferroada de Hymenoptera. TIPO DE ESTUDO E LOCAL: Foram revisados na literatura mundial ensaios clínicos controlados e aleatórios. O manuscrito foi realizado na Disciplina de Alergia e Imunologia Clínica, Universidade de São Paulo (USP). MÉTODOS: Ensaios clínicos controlados e aleatórios envolvendo imunoterapia com veneno de Hymenoptera versus placebo ou apenas acompanhamento dos pacientes foram avaliados. Realizada imunoterapia específica, o risco de reações sistêmicas foi avaliado através de cálculo do "odds ratio" e intervalo de confiança de 95 por cento. RESULTADOS: 2.273 resumos foram identificados na busca pelas palavras chave. Apenas quatro estudos foram incluídos nesta revisão. O teste qui-quadrado de heterogeneidade mostrou que dois estudos foram homogêneos e puderam ser incluídos na metanálise. Ao combinar os dois estudos, o "odds ratio" passou a ser significativo: 0.29 (0.10-0.87). Entretanto, ao analisar a gravidade das reações ocorridas após a imunoterapia, observou-se que os benefícios podem não ser tão relevantes, pois as reações foram, na grande maioria, ou mais leves ou semelhantes à reação original. CONCLUSÕES: A imunoterapia específica deve ser recomendada para adultos e crianças com reações moderadas a graves, porém não há necessidade de prescrevê-la para as crianças apenas com reações cutâneas, especialmente se a exposição é muito esporádica. No outro lado, a relação risco-benefício deve ser sempre avaliada em cada caso.

Effect of apitherapy on diminishing the incidence, of pneumoenteric infections in buffalo calves

This study was designed to evaluate the prophylactic effect of bee venom apipuncture on diminishing the prevalence of pneumonenteric infections in newly born buffalo calves. During the period of the study which lasted 6 weeks, a marked significant decrease of diarrhea and respiratory infections was observed in the bee venom treated calf group [n = 40] compared to the control group [n = 44]. In the bee venom treated group 17.5% of the calves showed undifferentiated diarrhea, 15% suffered pneumonia while 67.5% of the calves remained healthy in contrast to the control calf group in which prevalence of diarrhea and pneumonia were 29.5% and 18.5% respectively, whereas 45.5% remained healthy. No deaths occurred in the bee venom treated group, on the other hand, three calves died in the control group. The immunological investigation showed an improvement in the immune system as a result of bee venom apipuncture giving maximum antibodies production represented by a significant increase of IgG level. Accordingly we can conclude that bee venom could be used as a novel medication to improve the health condition and immunological status of buffalo calves without producing any side effects or allergic reactions

Inmunoterapia con veneno de himenópteros: presentación de diez casos clínicos / Immunotherapy against hymenoptera venom: Report of ten patients

Background: Immunotherapy can be used to treat allergic reactions to insect stings, specially bees and wasps. Aim: To report the experience with immunotherapy with aqueous extracts of hymenoptera venoms (bees and wasps). Material and methods: Ten patients aged 6 to 58 years were treated in an allergy center of a University Clinical Hospital. The medical indication for this treatment was, in all patients, anaphylactic reactions after hymenoptera stings. Immunotherapy was carried out using standardized vaccines (Aqueous extracts Venomvac LETI, Spain), applied in a traditional protocol, with subcutaneous injections. This protocol had two phases: a buildup phase (between weeks 1 and 13) and a monthly maintenance phase, from the 13th week. The monthly maintenance dose was 100 fig of hymenoptera specific venom extract. Results: Six patients had adverse reactions of different severity, during the treatment protocols and all had a good response to immediate therapeutic measures. After these events, they followed the protocol without problems. Two patients, treated with bee vaccines, suffered an accidental bee sting during the maintenance phase and they developed only local reactions. Conclusions: The lack of adverse reactions to bee stings in these two patients indicates the acquisition of clinical tolerance.

Características clínicas das reações por venenos de Hymenoptera e valor diagnóstico da determinação de IgE sérica específica nas alergias provocadas por estes insetos / Clinical characteristics of Hymenoptera venom reactions and the value of specific serum IgE determination in the diagnosis of these insect allergies

A ordem Hymenoptera é constituída pelas abelhas, vespas e formigas. Alergias aos venenos desses insetos podem ocasionar reações graves, muitas vezes fatais. O Brasil possui poucos dados epidemiológicos sobre alergia aos himenópteros e há poucos estudos que avaliem as características da determinação de IgE sérica específica e o seu papel no diagnóstico da alergia a estes insetos. Este trabalho tem como objetivo estudar os pacientes com alergia a himenópteros, em relação a parâmetros clínicos e testar o valor diagnóstico do método utilizado para a determinação sérica de IgE específica, de acordo com os parâmetros de sensibilidade, especificidade, valores preditivo positivo e negativo./The Hymenoptera order is constituted by bees, wasps and ants. The insect venoms allergies could provoke severe reactions, many times fatal. Brazil has few epidemiologic data about Hymenoptera allergy and there are few studies about specific serum IgE determination characteristics and its role in these insect allergies diagnosis. The aims of the present study are to analyze the patients with Hymenoptera allergy history based on clinical parameters and analyze the diagnostic value of the method used in specific serum IgE determination considering sensitivity, specificity, positive and negative predictive values...

Immunoblot analysis of IgE and IgG antibodies to honey bee venom: cross sectional and sequential studies in bee sensitive subjects.

To investigate the specific IgE and IgG immune response to honey bee venom (bv), we performed immunoblot analysis of sera from 47 bee sensitive subjects and followed the response during and after venom immunotherapy in 15 of these subjects. Fifteen venom proteins varying in molecular size from 20 to 105 kDa were identified as being antigenic and consisted of a high molecular weight (HMW) group (5 to 105 kDa, containing the previously identified allergens B and C) and a low molecular weight group (LMW) containing hyaluronidase and phospholipase A. In general for a given individual the anti-venom IgE and IgG response was qualitatively similar although some variation between individuals was apparent. Reactivity with hyaluronidase and phospholipase A appeared only in those subjects showing reactivity with HMW components. During immunotherapy specific anti-venom IgG and IgE responses tended to be linked. Increased responses being seen against all components in 4 of 12 subjects, reductions in 3 and unchanged responses in the remainder. Following immunotherapy (mean 4.0 years), spontaneous reduction of IgE and IgG was seen in 5 of 5 subjects. Loss of reactivity with the LMW components was prominent in these sera.